Development of Antibody as Carrier incorporating Platinum-Based Agent for targeted therapy of Colorectal Cancer
碩士 === 國立臺灣大學 === 醫學工程學研究所 === 104 === Using the combination of Panitumumab, a monoclonal antibody, and oxaliplatin, a Pt-based drug, to treat patient with colorectal cancers (CRC) is known to be effective in clinical. It is thought that Panitumumab can efficiently bind to EGFR, inhibiting cell gro...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2016
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/72185599032253019395 |